Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

PulldownID 6 from 'Atlas of the proteasome interactome by in situ structural biology'

ABSTRACT: All raw and processed Pulldown-ID mass-spectrometry datasets used in 'Atlas of the proteasome interactome by in situ structural biology': Pulldown ID-1 (non-crosslinked WT vs RPN1 tag); Pulldown ID-2 (crosslinked WT vs RPN1 tag); Pulldown ID-3 (non-crosslinked WT vs RPN11 tag); Pulldown ID-4 (crosslinked WT vs RPN11 tag); Pulldown ID-5 (non-crosslinked WT vs β4 tag); and Pulldown ID-6 (crosslinked WT vs β4 tag).

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Kitaik Lee

LAB HEAD: Francis J.O'Reilly

PROVIDER: PXD066284 | Pride | 2026-07-16

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E250403_01_KL_PSMB4_pulldownID_Control_XL_rep1_inj1.pepXML	Pepxml
	E250403_01_KL_PSMB4_pulldownID_Control_XL_rep1_inj1.pin	Other
	E250403_01_KL_PSMB4_pulldownID_Control_XL_rep1_inj1.png	Other
	E250403_01_KL_PSMB4_pulldownID_Control_XL_rep1_inj1.raw	Raw
	E250403_01_KL_PSMB4_pulldownID_Control_XL_rep1_inj1_edited.pin	Other

Items per page:

1 - 5 of 159

Similar Datasets

PulldownID 2 from 'Atlas of the proteasome interactome by in situ structural biology'

Project description:All raw and processed Pulldown-ID mass-spectrometry datasets used in 'Atlas of the proteasome interactome by in situ structural biology': Pulldown ID-1 (non-crosslinked WT vs RPN1 tag); Pulldown ID-2 (crosslinked WT vs RPN1 tag); Pulldown ID-3 (non-crosslinked WT vs RPN11 tag); Pulldown ID-4 (crosslinked WT vs RPN11 tag); Pulldown ID-5 (non-crosslinked WT vs β4 tag); and Pulldown ID-6 (crosslinked WT vs β4 tag).

2026-07-16 | PXD066280 | Pride

PulldownID 5 from 'Atlas of the proteasome interactome by in situ structural biology'

2026-07-16 | PXD066268 | Pride

PulldownID 3 from 'Atlas of the proteasome interactome by in situ structural biology'

2026-07-16 | PXD066279 | Pride

PulldownID 1 from 'Atlas of the proteasome interactome by in situ structural biology'

2026-07-16 | PXD066281 | Pride

PulldownID 4 from 'Atlas of the proteasome interactome by in situ structural biology'

2026-07-16 | PXD066278 | Pride

Cofractionation MS from 'Atlas of the proteasome interactome by in situ structural biology'

Project description:Cofractionation (SEC) LC–MS/MS dataset of purified proteasome complexes isolated from in situ–crosslinked RPN1-tag knock-in HCT116 cells.

2026-07-16 | PXD066287 | Pride

RPN1 pulldown ID with PSMD5 overexpression from 'Integrated structural biology and in situ crosslinking reveals UBE3C, TXNL1, and PSMD5 at proteasome complexes'

Project description:For PSMD5 over expression experiment, RPN1-tagged cells were transfected in either 6-well plates (Cat. No. 3506; Costar) or 10 cm dishes using 1 µg or 5 µg of HA-PSMD5, respectively. All the transfections were performed with Lipofectamine 3000 (Cat. No. L3000015; Thermo Fisher Scientific) in Opti-MEM reduced serum medium (Cat. No. 31985070; Life Technologies), following the manufacturer’s protocol. Cells were incubated at 37 °C in a humidified atmosphere containing 5 % CO₂ for 48 h before harvesting.

2026-07-16 | PXD066535 | Pride

Amelioration of nonalcoholic fatty liver disease by inhibiting the deubiquitylating enzyme RPN11 (MeRIP-m6A-mRNA-seq)

Project description:Nonalcoholic fatty liver disease (NAFLD) including its more severe manifestation, nonalcoholic steatohepatitis (NASH), is a global public health challenge with no approved pharmacological therapies. Here, we reveal an indispensable role for the deubiquitinating enzyme RPN11 in the development of NAFLD and NASH. Ablation of hepatic RPN11 markedly protected mice from several diets-induced liver steatosis, insulin resistance and steatohepatitis, whereas RPN11 overexpression had the opposite effects. Mechanistically, RPN11 interacts with and stabilizes METTL3 via deubiquitination initiated at lysine 241, to increase the m6A modification and expression of acyl-CoA synthetase short chain family member 3 (Acss3). RPN11-Acss3 axis generates propionyl-CoA and functions in histone propionylation to transcriptionally upregulate lipid metabolism-related genes. Of pathophysiological significance, RPN11-METTL3-Acss3-histone propionylation modification pathway is activated in the livers of patients with NAFLD and positively correlated with hepatic triglyceride contents. More importantly, pharmacological inhibition of RPN11 by Capzimin showed dramatic beneficial effects in ameliorating NAFLD, NASH and related metabolic disorders in mice. Capzimin also reduces intracellular lipid contents in human primary hepatocytes cultured in 2D and 3D spheroids. Together, these results demonstrate that RPN11 is essential for the development of NAFLD/NASH and that suppressing RPN11 has therapeutic potential for the treatment.

2024-08-14 | GSE263866 | GEO